Dan Brennan

Following a roadshow with CFO Dan Brennan of Boston Scientific Corporation (NYSE: BSX), RBC Capital’s Glenn Novarro expressed confidence regarding the company being a “multi-year revenue growth story, led by a deep pipeline.” Novarro maintains an Outperform rating on the company,...